Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade

Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade

Abstract A 69‐year‐old man with non‐small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long‐term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even...

Full description

Bibliographic Details
Main Authors: Tsuyoshi Uchida, Hirochika Matsubara, Mamoru Muto, Harunobu Sasanuma, Saya Sugimura, Yuichiro Onuki, Hiroyuki Nakajima
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Clinical Case Reports
Subjects:
cardiac tamponade
immunotherapy
non‐small cell lung cancer
pembrolizumab
radiotherapy
Online Access:https://doi.org/10.1002/ccr3.6795

Similar Items

Similar Items